IL10 and COVID-19: Individuals affected by COVID-19 who need treatment in intensive care units usually have high levels of interleukin (IL)-2, IL-7, IL-10, tumor necrosis factor α (TNF-α), and other pro-inflammatory and also anti-inflammatory cytokines.